These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 23599173)

  • 21. Cyclin G1 expands liver tumor-initiating cells by Sox2 induction via Akt/mTOR signaling.
    Wen W; Han T; Chen C; Huang L; Sun W; Wang X; Chen SZ; Xiang DM; Tang L; Cao D; Feng GS; Wu MC; Ding J; Wang HY
    Mol Cancer Ther; 2013 Sep; 12(9):1796-804. PubMed ID: 23804702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of mTOR signaling by oleanolic acid contributes to its anti-tumor activity in osteosarcoma cells.
    Zhou R; Zhang Z; Zhao L; Jia C; Xu S; Mai Q; Lu M; Huang M; Wang L; Wang X; Jin D; Bai X
    J Orthop Res; 2011 Jun; 29(6):846-52. PubMed ID: 21246613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of pRB, p16 and cyclin D1 in colonic carcinogenesis.
    Ayhan S; Isisag A; Saruc M; Nese N; Demir MA; Kucukmetin NT
    Hepatogastroenterology; 2010; 57(98):251-6. PubMed ID: 20583423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antitumor effect of GDC-0941 alone and in combination with rapamycin in breast cancer cells.
    Zheng J; Zou X; Yao J
    Chemotherapy; 2012; 58(4):273-81. PubMed ID: 23006739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LY303511 (2-piperazinyl-8-phenyl-4H-1-benzopyran-4-one) acts via phosphatidylinositol 3-kinase-independent pathways to inhibit cell proliferation via mammalian target of rapamycin (mTOR)- and non-mTOR-dependent mechanisms.
    Kristof AS; Pacheco-Rodriguez G; Schremmer B; Moss J
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1134-43. PubMed ID: 15923340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mammalian target of rapamycin inhibitor everolimus (RAD001) in early breast cancer: results of a pre-operative study.
    Macaskill EJ; Bartlett JM; Sabine VS; Faratian D; Renshaw L; White S; Campbell FM; Young O; Williams L; Thomas JS; Barber MD; Dixon JM
    Breast Cancer Res Treat; 2011 Aug; 128(3):725-34. PubMed ID: 20941539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ESM-1 regulates cell growth and metastatic process through activation of NF-κB in colorectal cancer.
    Kang YH; Ji NY; Han SR; Lee CI; Kim JW; Yeom YI; Kim YH; Chun HK; Kim JW; Chung JW; Ahn DK; Lee HG; Song EY
    Cell Signal; 2012 Oct; 24(10):1940-9. PubMed ID: 22735811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A combination of eicosapentaenoic acid-free fatty acid, epigallocatechin-3-gallate and proanthocyanidins has a strong effect on mTOR signaling in colorectal cancer cells.
    D'Angelo L; Piazzi G; Pacilli A; Prossomariti A; Fazio C; Montanaro L; Graziani G; Fogliano V; Munarini A; Bianchi F; Belluzzi A; Bazzoli F; Ricciardiello L
    Carcinogenesis; 2014 Oct; 35(10):2314-20. PubMed ID: 25123131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKα/mTOR pathway in vitro and in vivo.
    Fujihara S; Morishita A; Ogawa K; Tadokoro T; Chiyo T; Kato K; Kobara H; Mori H; Iwama H; Masaki T
    Oncotarget; 2017 Jan; 8(5):8536-8549. PubMed ID: 28052030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hcrcn81 is upregulated by rapamycin treatment in human colorectal adenocarcinoma cells.
    Wen X; Dong L; Zhu J; Chen Y
    Mol Med Rep; 2013 Apr; 7(4):1257-60. PubMed ID: 23404111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AIM2 inhibits colorectal cancer cell proliferation and migration through suppression of Gli1.
    Xu M; Wang J; Li H; Zhang Z; Cheng Z
    Aging (Albany NY); 2020 Dec; 13(1):1017-1031. PubMed ID: 33291082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of Rab31 is associated with poor prognosis and promotes colorectal carcinoma proliferation via the mTOR/p70S6K/Cyclin D1 signalling pathway.
    Yang L; Tian X; Chen X; Lin X; Tang C; Gao Y; Chen S; Ge Z
    Life Sci; 2020 Sep; 257():118126. PubMed ID: 32707053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-Aminosalicylic acid inhibits cell cycle progression in a phospholipase D dependent manner in colorectal cancer.
    Baan B; Dihal AA; Hoff E; Bos CL; Voorneveld PW; Koelink PJ; Wildenberg ME; Muncan V; Heijmans J; Verspaget HW; Richel DJ; Hardwick JC; Hommes DW; Peppelenbosch MP; van den Brink GR
    Gut; 2012 Dec; 61(12):1708-15. PubMed ID: 22187071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PI-3K/Akt signal pathway plays a crucial role in arsenite-induced cell proliferation of human keratinocytes through induction of cyclin D1.
    Ouyang W; Li J; Zhang D; Jiang BH; Huang DC
    J Cell Biochem; 2007 Jul; 101(4):969-78. PubMed ID: 17370311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of fatty acid synthase suppresses the malignant phenotype of colorectal cancer cells by down-regulating energy metabolism and mTOR signaling pathway.
    Chang L; Wu P; Senthilkumar R; Tian X; Liu H; Shen X; Tao Z; Huang P
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):59-72. PubMed ID: 26109148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of mTOR signaling and its inhibitor against cancer stem-like cells in colorectal cancer.
    Cai Z; Ke J; He X; Yuan R; Chen Y; Wu X; Wang L; Wang J; Lan P; Wu X
    Ann Surg Oncol; 2014 Jan; 21(1):179-88. PubMed ID: 23907312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical analysis of the mammalian target of rapamycin signalling pathway in extramammary Paget's disease.
    Chen S; Nakahara T; Uchi H; Takeuchi S; Takahara M; Kido M; Dugu L; Tu Y; Moroi Y; Furue M
    Br J Dermatol; 2009 Aug; 161(2):357-63. PubMed ID: 19438435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homocysteine induces smooth muscle cell proliferation through differential regulation of cyclins A and D1 expression.
    Chiang JK; Sung ML; Yu HR; Chang HI; Kuo HC; Tsai TC; Yen CK; Chen CN
    J Cell Physiol; 2011 Apr; 226(4):1017-26. PubMed ID: 20857402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ChIP-seq and functional analysis of the SOX2 gene in colorectal cancers.
    Fang X; Yu W; Li L; Shao J; Zhao N; Chen Q; Ye Z; Lin SC; Zheng S; Lin B
    OMICS; 2010 Aug; 14(4):369-84. PubMed ID: 20726797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lentivirus-mediated RNA interference targeting WWTR1 in human colorectal cancer cells inhibits cell proliferation in vitro and tumor growth in vivo.
    Pan J; Li S; Chi P; Xu Z; Lu X; Huang Y
    Oncol Rep; 2012 Jul; 28(1):179-85. PubMed ID: 22470139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.